MRNA
Product
by Moderna, Inc.
The Nasdaq stock ticker for Moderna, Inc., a biotechnology company focused on mRNA-based medicines and vaccines.
Discussed alongside MRNA
- Moderna
Organization · 6 episodes together · 2 shows
- Merck KGaA
Organization · 2 episodes together · 1 show
- Emily Graffeo
Person · 2 episodes together · 1 show
- Avalon Purnell
Person · 2 episodes together · 1 show
6 episodes featuring MRNA
Stock Movers
Three stocks expose AI fervor, deal risk and biotech promise
The episode shows how product momentum, acquisition speculation and clinical data can drive sharply different market reactions in one week.
Sep 25, 2026 · 5 min
Stock Movers
Shopify, Moderna and On ride distinct catalysts
The episode shows how AI partnerships, cancer-vaccine data and expansion plans can move very different companies’ shares.
Sep 22, 2026 · 7 min
Equity Mates Investing Podcast
AI spending strains markets as growth investors rethink risk
The episode connects AI infrastructure’s uncertain economics with a disciplined investing framework built to capture growth while limiting drawdowns.
Sep 3, 2026 · 49 min
Stock Movers
Earnings winners collide with Moderna’s record reversal
The episode shows how guidance, expectations, and valuation can overpower even encouraging business or clinical news.
Aug 20, 2026 · 6 min
Stock Movers
Moderna advances cancer vaccine as rail merger review resumes
The episode connects a promising personalized cancer-vaccine result with consequential corporate outlooks and a revived regulatory review of a major rail bid.
Aug 19, 2026 · 5 min
Stock Movers
Moderna rallies as buybacks and turnarounds test markets
The episode connects three sharp stock moves to bigger questions about biotech breakthroughs, shareholder returns, corporate recovery, and urban resilience.
Aug 19, 2026 · 8 min